Sarepta Therapeutics Inc (SRPT)
114.23
+3.73
(+3.38%)
USD |
NASDAQ |
Nov 22, 16:00
114.23
0.00 (0.00%)
After-Hours: 20:00
Sarepta Therapeutics Total Return Price: 114.23 for Nov. 22, 2024
Total Return Price Chart
Historical Total Return Price Data
Date | Value |
---|---|
November 22, 2024 | 114.23 |
November 21, 2024 | 110.50 |
November 20, 2024 | 110.86 |
November 19, 2024 | 106.62 |
November 18, 2024 | 104.67 |
November 15, 2024 | 104.54 |
November 14, 2024 | 109.11 |
November 13, 2024 | 112.48 |
November 12, 2024 | 114.32 |
November 11, 2024 | 117.84 |
November 08, 2024 | 121.61 |
November 07, 2024 | 120.42 |
November 06, 2024 | 127.97 |
November 05, 2024 | 125.01 |
November 04, 2024 | 123.07 |
November 01, 2024 | 123.29 |
October 31, 2024 | 126.00 |
October 30, 2024 | 127.78 |
October 29, 2024 | 130.21 |
October 28, 2024 | 130.26 |
October 25, 2024 | 131.14 |
October 24, 2024 | 132.02 |
October 23, 2024 | 129.88 |
October 22, 2024 | 128.42 |
October 21, 2024 | 127.31 |
Date | Value |
---|---|
October 18, 2024 | 127.08 |
October 17, 2024 | 124.25 |
October 16, 2024 | 125.92 |
October 15, 2024 | 123.73 |
October 14, 2024 | 124.37 |
October 11, 2024 | 124.51 |
October 10, 2024 | 122.41 |
October 09, 2024 | 117.99 |
October 08, 2024 | 119.72 |
October 07, 2024 | 117.79 |
October 04, 2024 | 120.40 |
October 03, 2024 | 118.76 |
October 02, 2024 | 122.52 |
October 01, 2024 | 122.33 |
September 30, 2024 | 124.89 |
September 27, 2024 | 124.53 |
September 26, 2024 | 124.84 |
September 25, 2024 | 124.62 |
September 24, 2024 | 125.49 |
September 23, 2024 | 124.79 |
September 20, 2024 | 127.21 |
September 19, 2024 | 127.10 |
September 18, 2024 | 125.01 |
September 17, 2024 | 125.69 |
September 16, 2024 | 124.33 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
62.69
Minimum
Jun 16 2022
178.74
Maximum
Dec 22 2020
111.31
Average
114.78
Median
Total Return Price Benchmarks
Eli Lilly and Co | 748.01 |
Catalyst Pharmaceuticals Inc | 21.48 |
Regeneron Pharmaceuticals Inc | 738.00 |
Vertex Pharmaceuticals Inc | 450.97 |
Viking Therapeutics Inc | 52.59 |